Liu, Ming https://orcid.org/0000-0003-3567-530X
Vandekeere, Anke https://orcid.org/0000-0001-6836-3834
Liu, Xiao-Zheng https://orcid.org/0000-0002-8452-6848
Schenck, Stephan https://orcid.org/0000-0001-6639-0484
Fernández-García, Juan https://orcid.org/0000-0003-3422-3627
Tricot, Tine https://orcid.org/0000-0002-6710-4838
Peng-Winkler, Yiming https://orcid.org/0000-0002-8327-559X
Demicco, Margherita https://orcid.org/0000-0002-9396-3281
Broekaert, Dorien https://orcid.org/0000-0002-9777-1607
Vermeire, Ines https://orcid.org/0000-0003-3366-7410
Theile, Janine https://orcid.org/0009-0006-1155-7594
Zels, Gitte https://orcid.org/0000-0002-6332-3830
Pabba, Anirudh
Desmedt, Christine
Brunner, Janine D. https://orcid.org/0000-0003-4237-9322
Altea-Manzano, Patricia https://orcid.org/0000-0002-7075-2051
Fendt, Sarah-Maria https://orcid.org/0000-0001-6018-9296
Article History
Received: 20 February 2025
Accepted: 13 February 2026
First Online: 13 March 2026
Competing interests
: S.-M.F. has received funding from BlackBelt Therapeutics, Auron Therapeutics and Alesta Therapeutics, is on the advisory board of Alesta Therapeutics and has consulted for Fund+ and Droia Ventures. All other authors declare no competing interests.